79 filings
10-K/A
2023 FY
ELYM
Eliem Therapeutics Inc
Annual report (amended)
29 Apr 24
4:02pm
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
ELYM
Eliem Therapeutics Inc
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
S-8
ELYM
Eliem Therapeutics Inc
28 Mar 24
Registration of securities for employees
4:27pm
10-K
2023 FY
ELYM
Eliem Therapeutics Inc
Annual report
28 Mar 24
4:05pm
8-K
lx6 eyzyf7d0iuje
18 Mar 24
Other Events
6:34pm
8-K
jpfk06
20 Jul 23
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
6:55am
8-K
98eqyv
19 May 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
h2s0onk7e8ro1m
11 May 23
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
4:12pm
ARS
iezjpz4m
6 Apr 23
Annual report to shareholders
4:15pm
DEFA14A
yzcsi
6 Apr 23
Additional proxy soliciting materials
4:10pm
8-K
4vmt6kr7wouz5rwywn
16 Mar 23
Departure of Directors or Certain Officers
4:30pm
S-8
dw1d0c2yefzezh1alwxr
6 Mar 23
Registration of securities for employees
4:59pm
8-K
z2y4q9k1
6 Mar 23
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
4:52pm
8-K
8sdfmoe
13 Feb 23
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
9:09pm